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Summary. Factoi VIII activity (factor VIII C) and factor VIII
antigen (factor VIII Ag) levels abovelSO lU/dl are associated
with a five- to sixfold increased nsk of venous thrombosis
compared with levels < 100 lU/dl These high levels are
present in 25% of patients with a first episode of deep-vem
thrombosis and in 11% of healthy controls von Willebrand
lactor (VWF) and blood group are impoitant determmants
of the factor VIII level m plasma and therefoie contnbute to
thrombotic nsk, while factor VIII appears to be the final
effector Previously, we found famihal clustermg of factor
VIII C levels m women which remamed after adjustment for
VWF and blood group In the present study, we analysed the
famihal influence on factor VIII Ag levels exceeding
ISO lU/dl in 12 large families with thrombophilia in
which high factor VIII Ag levels contnbute to thrombotic
nsk As expected, blood group was a mam determmant of
the plasma factor VIII level 58 relatives (32%) had factor
VIII levels above 150 Ιϋ/dl and 50 (86%) of these had blood
group non-0 After adjustment for blood group and age, we
found an association between factor VIII Ag levels m sister
pairs (0 35, P = 0 003), brother pairs (0 35, P = 0 003),
brother-sister pairs (0 35, P < 0 001) and in mother-son
pairs (0 45 P = 0 02), but not in father-daughter or
father-son pairs The famihal aggregation test was strongly
positive for factoi VIII Ag levels (P < 0 001) and remamed
so after adjustment for the influence of blood group We
conclude that high factor VIII Ag levels are a highly
prevalent nsk factoi for venous thrombosis and contnbute
to risk m families with thrombophilia, and that these high
levels are hkely to be genetically determmed by factors other
than just blood group
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Elevated factor VIII activity (factor VIII C) levels are associ-
ated with an increased nsk of venous thrombosis (Koster
et al, 1995) Factor VIII C levels higher than 150 lU/dl
mcrease the thrombosis nsk five- to sixfold compaied with
levels below 100 Ιϋ/dl (Koster et al, 1995) von Willebrand
factor (VWF) and blood group are well-known determmants
of the factor VIII level m plasma and so contnbute to
thrombotic nsk, whereas factor VIII itself appears to be the
final effector m promotmg thrombosis (Koster et al, 1995)
Elevated factor VIII C levels are highly correlated with factor
VIII antigen (factor VIII Ag) levels (Kamphmsen etal, 1997,
O'Donnell et al, 1997) This suggests that the observed
elevation of factor VIII C levels reflects a true mcrease in
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factor VIII protem and is not the lesult of activation of the
coagulation System during the blood collection procedure
(Kamphmsen et al, 1997, O'Donnell et al, 1997) Factor
VIII Ag levels above 150 lU/dl were, hke factor VIII C levels,
also associated with a flvefold increased nsk of venous
thrombosis (Kamphuisen et al 1997) We have recently
shown that elevated factor VIII levels m thrombosis patients
aie not the result of acute phase reactions because elevated
factor VIII levels remamed associated with a sixfold increased
risk after adjustment for C-reactive protem (CRP), a sensitive
marker for acute phase processes (Kamphuisen ei al, 1999)
These observations lend further support to a causal relation-
ship between high factor VIII levels and venous thrombosis
High factor VIII levels are common, m our study, 25% of
the patients with a first episode of venous thrombosis and
11% of the healthy controls had factor VIII levels above
150 lU/dl (Koster et al, 1995) Considering the sixfold
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increased thrombosis risk and the high prevalence in the
Population, factor VIII levels exceeding 150 lU/dl contribute
importantly to deep-vein thrombosis.
We previously reported that factor VIII: C levels show a
familial clustering, which remains after correction for VWF
and blood group (Kamphuisen et al, 1998). That study was
performed in female relatives of probands with documented
haemophilia A who came to the Leiden haemophilia centre
for carriership testing. We designed a study that allowed us to
incorporate a large number of families that were seen over a
period of more than 10 years for carrier testing. However, the
design of this study also had several drawbacks. First, factor
VIII:C levels were measured over a 10-year period, which
might have led to extra Variation in the plasma factor VIII
level. Furthermore, only women were tested, which provides
less information on familial clustering than when both
women and men are tested. And, fmally, in this group of
women, high levels of factor VIII were not äs common äs
among patients with thrombosis, and the association
between levels and thrombosis was not studied nor was
the heritability of high levels (above 150 lU/dl) itself.
In the present study, we have analysed the familial
aggregation of factor VIII levels in men and women of 12
large families with thrombophilia who had a proband with
both venous thrombosis and factor V Leiden. In these
families, factor VIII:Ag levels above 150 lU/dl contribute to
the thrombosis risk of factor V Leiden carriers (Lensen et al,
1999). We tested whether clustering of factor VIII:Ag levels
higher than 150 lU/dl occurred and the effect of blood
group on these high levels.
SUBJECTS AND METHODS
Family data. The 12 probands originated from a larger
panel of 28 patients who were referred to our centre for
diagnostic work-up for venous thrombophilia, i.e. patients
with a positive family history of venous thrombosis (in
addition to the proband, at least two symptomatic relatives),
and who did not have deficiencies of protein C, protein S or
antithrombin. These 28 patients were screened for the
presence of the factor V Leiden mutation that was detected
in 12 patients. We invited the siblings, parents and children
of these 12 probands äs well äs uncles and aunts of the
affected parental side and, if these were carriers, their
children (first cousins of the proband). Family members
under 15 years of age were excluded for practical purposes.
Of the 12 probands, 182 family members (93%) participated
in the study while 12 did not, three because they lived
abroad and nine for reasons unknown.
The probands and family members were not selected on
the basis of factor VIII:Ag levels because these levels were
not known at that Urne.
Laboratory assays. Blood was collected from the ante-
cubital vein in 0-106 M trisodium citrate. ABO phenotypes
were deduced from the reactions of plasma isoagglutinins to
AI, B, A1B or (äs negative control) 0 test blood cell
suspensions (3% v/v) in a Standard spin-tube agglutination
technique carried out at room temperature (Walker, 1990).
All the subjects were considered to be immune competent and
free from malignancy or infection. The chance of an ABO
misphenotyping because of the absence of the appropriate
isoagglutinin, anomalous occurrence of anti-A or -B or
acquisition of a B-antigen was considered to be unlikely.
Factor VIII antigen was measured by a Sandwich type
enzyme-linked immunosorbent assay (ELISA) using two
monoclonal antibodies directed against the light chain of
factor VIII (Kamphuisen ei al, 1997). Pooled normal plasma,
calibrated against the WHO Standard (91/666) for factor
VIILAg, was used äs a reference.
Staüstical analysis. The distribution of factor VIII:Ag levels
was skewed and was logarithmically transformed for all
statistical analyses. The analysis was performed using linear
regression, with age entered äs a continuous variable (in
years), and blood group dichotomized into two groups (0 for
blood group 0, l for non-0).
To investigate genetic effects on factor VIII:Ag levels, the
residuale of the multiple regression models were used.
Residuais are the differences between the observed level Y,
for person i and the predicted value μ, obtained from the
multiple regression model. As a first test for familial effects,
correlations between the residuale (obtained from the
multiple regression model) of pairs of relatives were
calculated. Familial aggregation of factor VIIIiAg levels
was studied using a recently developed method (Houwing-
Duistermaat et al, 1995) that tests the null hypothesis of no
correlation within randomly chosen pedigrees. The correla-
tion of the genetic effects is tested by the weighted sum of
correlations between pairs of relatives within a pedigree 0.
The test for familial aggregation is positive when the
calculated Q is larger than the expected 0-value under the
null hypothesis of no aggregation (for more details, see
Houwing-Duistermaat ei al, 1995; Kamphuisen et al, 1998).
The familial clustering of factor VIII levels exceeding
150 lU/dl was tested with the individual factor VIII level
dichotomized into two groups (Y, = 0 for factor VIII:Ag
levels < 150 lU/dl, Y, = l for factor VIII:Ag levels
s 150 lU/dl). In this way, the value of 0 will be determined
mainly by pairs of relatives who both have factor VIII levels
higher than 150 lU/dl.
RESULTS
We studied 182 relatives of 12 probands with factor V
Leiden and a positive family history of venous thrombosis.
The mean size of the families was 19 members, with a ränge
from 3 to 29 members. The mean age at the time of the
study was 40 years (ränge 15-88 years); 92 (50%) were
men and 90 were women. Of these 182 relatives, 91 were
heterozygous for factor V Leiden, one relative was homo-
zygous and 90 were non-carriers.
Mean factor VIII:Ag level was 137 lU/dl with a ränge
between 54 and 339 lU/dl. Plasma factor VIII:Ag levels
were not clearly different in factor V Leiden carriers
[142 lU/dl; 95% confidence interval (CI) 132-151 U/dl]
and non-carriers (132 lU/dl; 95% CI 121-142 U/dl).
Factor VIII:Ag levels were higher in the 126 subjects
(69%) with blood group non-0 than in the 56 subjects
(31%) with blood group 0 (150 vs. 107 lU/dl) (mean
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Table I. Conelation coefficients for factor VIII Ag levels between
first-degree relative pairs *





























*Adjusted for age and blood group
difference 43 lU/dl, 95% CI 29-57 lU/dl) Factor VIII levels
were above 150 lU/dl m 58 mdividuals (32%) Of these
mdividuals, 50 subjects had blood group non-0 (86%) and
eight (14%) had blood group 0
We tested the correlaüons of factor VIII Ag levels between
all first-degree relative pairs After adjustment for blood
group and age, the factor VIII levels in sibhngs showed a
strong association (Table I) In sister pairs, the correlation of
factor VIII levels was 0 35 (P = 0 003) and m biother pairs
it was 035 (P = 0 004), whereas m brother-sistei. pairs
this correlation was 031 (P < 0 001) In mother-son
pairs, factor VIII Ag levels were also highly correlaled
(r = 0 45, P = 0 02) The other first-degree lelationships
showed no clear correlaüons (Table I)
We assessed the familial clustering of factor VIII Ag levels
with the familial aggregation test Table II shows that when
factor VIII Ag levels are tested äs contmuous variables the
familial aggregation statistic 0 was clearly higher than the
expected Q under the null hypothesis of no correlation, also
afler adjustment for age and blood group Unadjusted, Q
was 308, whereas the expected value of no correlation was
175 (P < 0 001) Adjusted Q was 301 with an expected Q
of 172 (P < 0 001) Table III shows the familial clustering
of factor VIII levels above 150 lU/dl äs a dichotomized
variable The familial aggregation test was strongly positive
agam In this test, Q was l 65 wilh an expected value of no
correlation of 0 9 7 (P < 0 001) Adjustment for blood
group and age did not essentially change 0 (Table III)
DISCUSSION
Our study showed that within thrombophiha famüies factor
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*Adjusted for age and blood group
VIII Ag levels are highly aggregated The families we studied
had thrombophiha, in which high factor VIII levels
contnbute to the nsk of factor V Leiden carners (Lensen
et al, 1999) Familial clustering of factor VIII Ag levels
higher than 150 lU/dl was clearly demonstrated by the
familial aggregation test, and this remamed after adjust-
ment for the effects of blood group and age This suggests a
genetic mfluence on high factor VIII levels other than just
blood gioup
Familial aggregation was prominent, mdicatmg that
factoi VIII levels were strongly influenced by familial
factors The support for familial aggregation of factor VIII
levels was much stronger for the families studied here than
that obtamed with the female relatives of haemophilia A
patients tested in oui previous study (Kamphuisen et al,
1998) This might have been the result of the larger size of
the famihes which positively influenced the statistic Q of
familial aggregation The inclusion of men and women
tested in the present study could also affect the outcome
because the familial aggregation test uses all possible
combmations withm pedigrees Further, factor VIII levels
were measured over a much shorter penod than m our
previous study (< 4 weeks), which will reduce mterassay
vanations m the factor VIII level
These are famihes with thrombophiha who will probably
have several nsk factors for thrombosis As high factor VIII
levels are associated with venous thrombosis, we may have
selected foi high factor VIII levels m choosmg these famihes
This is reflected by the higher number of factor VIII levels
above 150 lU/dl in the thrombophiha famihes (32%) than
m the thrombosis patients m the LETS study (25%) (Koster
et al, 1995) The calculated 0 of familial aggregation for
high factor VIII levels is mamly the result of concordant
pairs with high factoi VIII levels The probabihty that
siblmgs have both elevated factor VIII levels is more hkely in
famihes that have a high prevalence of elevated factor VIII
levels than in famihes m which low factor VIII levels are
more common This means that a selection for high factor
VIII levels m famihes will underestimate the hentabihty of
high factor VIII levels
In this study, correlations of factor VIII Ag levels between
fust-degree relatives only parüally confirm the theory that
Variation of plasma factor VIII levels is under control of
X-hnked alleles (Fihppi et al, 1984) After adjustment for
the effect of blood group and age, factor VIII levels
correlated in siblmgs and m mother-son pairs but not m
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mother-daughter, father-daughter or father-son pairs.
Especially the finding that factor VIII levels were not
correlated m father-daughter pairs, who share the same
X-chromosome, does not support an X-Iinked determinant
of factor VIII levels We have to consider the possibility that
the correlation of factor VIII between fathers and daughters
is lowered by the maternal X-chromosome of the daughter.
A daughter who has a father with high factor VIII and a
mother with low factor VIII may have an mtermediate
factor VIII level This will negatively influence the correla-
tion between father and daughter. Very recently, Mansvelt
et al (1998) investigated the promoter and 3' termmus of
the factor VIII gene for vanations associated with high
factor VIII:C levels, but found none. It remains possible that
a part of the Variation of factor VIII is determmed by genetic
factors located on the X-chromosome, outside the factor VIII
gene We can also not rule out the possibility that
environmental factors and clustering withm famihes also
contnbute to the familial aggregation of high factor VIII.
The mean difference m factor VIII Ag level between blood
group 0 and non-0 was 43 lU/dl Among subjects with
factor VIII levels above ISO lU/dl, 86% had blood group
non-0, indicatmg that a substantial part of the elevation in
factor VIII is attnbutable to blood group. Most of the effect of
blood group on the factor VIII level is mediated through
VWF (Koster et al, 1995; Kamphuisen et al, 1998), but the
exact mechamsm öl how ABO blood group mfluences VWF
is unclear Blood group A, B and H(0) oligosacchande
structures have been identified on VWF (Sodetz et al, 1979;
Matsui et al, 1992). As modification of carbohydrates has
been shown to influence the half-life of VWF m the circu-
laüon in animal models (Stoddart et al, 1996; Sodetz et al,
1977), it is possible that ABO blood group determmants
affect the clearance of VWF in plasma VWF is an important
determinant of the factor VIII level in plasma, which is
explamed by VWF bemg the carrier protem for factor VIII
(Tuddenham et al, 1982, Bnnkhous et al, 1985) Whether
the different types of ABO blood group also influence the
factor VIII survival in plasma remains to be determmed.
We conclude that there is strong support that factor VIII
levels exceeding 150 lU/dl aggregate in famihes, also after
adjuslment for blood group and age. This is further evidence
that the high plasma factor VIII levels that previously were
found to be associated with a thrombotic risk in case-
control and family studies are determmed by genetic factors
other than just blood group.
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